Back to Search

MUHAMMED SAIF, MD

MD

Addiction Medicine (Psychiatry & Neurology) Physician

NPI: 1396276697IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

63943(NY)
Addiction Medicine (Psychiatry & Neurology) PhysicianPrimary

Psychiatry & Neurology — Addiction Medicine

Code: 2084A0401X

297803(NY)

CMS Specialties

PrimaryPSYCHIATRY

Education

ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY

Class of 2017

Research & Publications (20)

Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
PMID 19663627·Expert Opin Drug Saf·2009
8-other
Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.
PMID 19581758·JOP·2009
5-case
Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581737·JOP·2009
6-review
New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581736·JOP·2009
8-other
Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581735·JOP·2009
8-other
Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581734·JOP·2009
8-other
Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
PMID 19581733·JOP·2009
8-other
The use of real-time online updates for physicians.
PMID 19581732·JOP·2009
8-other
Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
PMID 19527102·Cutan Ocul Toxicol·2009
5-case
Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.
PMID 19514925·Cutan Ocul Toxicol·2009
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
47 NEW SCOTLAND AVE
ALBANY, NY 12208

Locations (2)

Practice Location

47 NEW SCOTLAND AVE, ALBANY, NY
(518) 262-5756

Practice Location

315 S MANNING BLVD STE 6408A, ALBANY, NY
(518) 525-1303

Quick Facts

NPI
1396276697
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
9
Publications
20

Are you this provider?

Claim Your Profile